| Net Cash Provided by (Used in) Operating Activities |
$3,500 |
USD |
17% |
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q2 2024 |
Q2 2024 |
| Common Stock, Shares, Issued |
3,332,200 |
shares |
0% |
Q2 2024 |
Q2 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$3,500 |
USD |
-188% |
Q1 2024 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$2,824 |
USD |
-70% |
Q3 2024 |
Q3 2024 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q2 2024 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q2 2024 |
Q2 2024 |
| Additional Paid in Capital |
$713,573 |
USD |
0% |
Q3 2024 |
Q3 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q2 2024 |